TheraSense develops, manufactures and markets FreeStyle(R) blood glucose self-monitoring systems, and is a leader in developing systems that feature a very small sample size, rapid test results and less painful testing.
TheraSense was acquired by Abbott Laboratories on January 13, 2004.
Join Mergr to view all 65 acquisitions of medical products companies in 2004, including 16 acquisitions by private equity firms, and 49 by strategics.
Out of 60 sectors in the Mergr database, medical products ranked 13 in number of deals in 2004. The largest medical products acquisition in 2004 was ALARIS Medical Systems - which was acquired by Cardinal Health for $1.6B.
Join Mergr to view this profile - and discover more medical products acquisitions of companies like TheraSense.
No obligation. Cancel anytime.